Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Our products
& pipeline
Diseases we target
GS010 for LHON
GS030 for Retinitis Pigmentosa
GS030 for Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Investors
& media
Company Overview
Press releases
Events & presentations
News and press coverage
Stock information
Governance
Documentation
Corporate
Year
All
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
News type
All
Regulatory
Clinical
Conferences
Corporate
Finance
General Meeting
Product candidates
Science & Technology
Other
Subject
All
Company and personnel
GS010 - LUMEVOQ
GS030
Technologies
Other
06 September 2021
UK MHRA grants GenSight Biologics’ LUMEVOQ® ophthalmic gene therapy Promising Innovative Medicine designation
07 Sep 2021
Redburn Gene Therapy Virtual Summit 2021
01 September 2021
Clinical Data on GenSight Biologics’ LUMEVOQ® and GS030 Gene Therapies to be Presented at 2021 ISGEDR and Several Investor and Industry Meetings in September
29 July 2021
GenSight Biologics Reports Interim Financial Results for the First Half of 2021 and Provides Operational Update
20 Jul 2021
OIS European Innovation Showcase – Virtual
07 Jul 2021
French Retail Investors Webcast on the Topline Results from REFLECT Phase III Clinical Trial of LUMEVOQ®
09 Jul 2021
KOL Webcast on the Topline Results from REFLECT Phase III Clinical Trial of LUMEVOQ®
05 July 2021
GenSight Biologics to Host Key Opinion Leader Webcasts on the Topline Results from REFLECT Phase III Clinical Trial of LUMEVOQ®
05 July 2021
GenSight Biologics Announces Approval of the LUMEVOQ® Cohort Temporary Authorization for Use (ATUc) in France
30 June 2021
GenSight Biologics Reports Topline Results from REFLECT Phase III Clinical Trial, Confirming LUMEVOQ® Efficacy Including Better Efficacy with Bilateral Treatment
View previous 9 articles
1
2
3
4
5
6
7
…
13
View next 9 articles
Go back to the page of the page